Screening for antimicrobial activity of ten medicinal plants used in Colombian folkloric medicine: A possible alternative in the treatment of non-nosocomial infectionsJhon J Rojas, #1 Veronica J Ochoa,#1 Saul A Ocampo,#1 and John F Muñoz#1
1Department of Pharmacy, Universidad de Antioquia, Cll. 67 # 53-108 of. 1-157, Medellín, ColombiaCorresponding author.
#Contributed equally.Jhon J Rojas: [email protected]; Veronica J Ochoa: [email protected]; Saul A Ocampo:[email protected]; John F Muñoz: jmuñ[email protected] July 4, 2005; Accepted February 17, 2006.This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
This article has been cited by other articles in PMC.
Other Sections▼
Abstract
Background
The antimicrobial activity and Minimal Inhibitory Concentration (MIC) of the extracts
ofBidens pilosa L., Bixa orellana L., Cecropia peltata L., Cinchona officinalis L.,Gliricidia
sepium H.B. & K, Jacaranda mimosifolia D.Don, Justicia secunda Vahl.,Piper
pulchrum C.DC, P. paniculata L. and Spilanthes americana Hieron were evaluated against
five bacteria (Staphylococcus aureus, Streptococcus β hemolític,Bacillus
cereus, Pseudomonas aeruginosa, and Escherichia coli), and one yeast (Candida albicans).
These plants are used in Colombian folk medicine to treat infections of microbial origin.
Methods
Plants were collected by farmers and traditional healers. The ethanol, hexane and water
extracts were obtained by standard methods. The antimicrobial activity was found by using
a modified agar well diffusion method. All microorganisms were obtained from the American
Type Culture Collection (ATCC). MIC was determined in the plant extracts that showed
some efficacy against the tested microorganisms. Gentamycin sulfate (1.0 μg/ml),
clindamycin (0.3 μg/ml) and nystatin (1.0 μg/ml) were used as positive controls.
Results
The water extracts of Bidens pilosa L., Jacaranda mimosifolia D.Don, and Piper
pulchrum C.DC showed a higher activity against Bacillus cereus and Escherichia coli than
gentamycin sulfate. Similarly, the ethanol extracts of all species were active
against Staphylococcus aureus except for Justicia secunda. Furthermore, Bixa
orellana L, Justicia secunda Vahl. and Piper pulchrum C.DC presented the lowest MICs
against Escherichia coli (0.8, 0.6 and 0.6 μg/ml, respectively) compared to gentamycin
sulfate (0.9 8g/ml). Likewise, Justicia secunda and Piper pulchrum C.DC showed an
analogous MIC against Candida albicans (0.5 and 0.6 μg/ml, respectively) compared to
nystatin (0.6 μg/ml). Bixa orellana L, exhibited a better MIC againstBacillus cereus (0.2
μg/ml) than gentamycin sulfate (0.5 μg/ml).
Conclusion
This in vitro study corroborated the antimicrobial activity of the selected plants used in
folkloric medicine. All these plants were effective against three or more of the pathogenic
microorganisms. However, they were ineffective
against Streptococcus βhemolytic and Pseudomonas aeruginosa. Their medicinal use in
infections associated with these two species is not recommended. This study also showed
thatBixa orellana L, Justicia secunda Vahl. and Piper pulchrum C.DC could be potential
sources of new antimicrobial agents.
Other Sections▼
Background
In developing countries and particularly in Colombia, low income people such as farmers,
people of small isolate villages and native communities use folk medicine for the treatment
of common infections. These plants are ingested as decoctions, teas and juice preparations
to treat respiratory infections[1]. They are also made into a poultice and applied directly on
the infected wounds or burns.
When people from these remote communities get an infectious disease, they are usually
treated by traditional healers and shamans because of their expertise in such procedures as
making diagnoses, treating wounds, setting bones and making herbal medicines. Traditional
healers claim that their medicine is cheaper and more effective than modern medicine.
Patients of these communities have a reduced risk to get infectious diseases from resistant
pathogens than people from urban areas treated with traditional antibiotics. However, if they
are treated in a hospital the chance of contracting a nosocomial infection is increased[2].
One way to prevent antibiotic resistance of pathogenic species is by using new compounds
that are not based on existing synthetic antimicrobial agents[3]. Traditional healers claim
that some medicinal plants such as bixa spp. and bidens spp. are more efficient to treat
infectious diseases than synthetic antibiotics. It is necessary to evaluate, in a scientific
base, the potential use of folk medicine for the treatment of infectious diseases produced by
common pathogens. Medicinal plants might represent an alternative treatment in non-
severe cases of infectious diseases. They can also be a possible source for new potent
antibiotics to which pathogen strains are not resistant. [4].
We chose ten species used in folk medicine to determine their antimicrobial activity:B.
pilosa L. (Asteraceae), B. orellana L. (Bixaceae), C. peltata L. (Moraceae), C. officinalis L.
(Rubiaceae), G. sepium H.B. & K (Fabaceae), J. mimosifolia D.Don(Bignoniaceae), J.
secunda Vahl. (Acanthaceae), P. pulchrum C.DC (Piperaceae),P. paniculata L.
(Polygalaceae), and S. americana Hieron (Asteraceae). In general, these plants are used in
folk medicine in the treatment of pharyngitis, gingivitis, bronchitis, infected wounds, topical
ulcers, and as antiparasitic agents.
The extract of B. pilosa is used in folk medicine as an antihelmintic and protozoacide agent;
it also has antiseptic properties[5]. It contains flavonoids [6]. The ethanol extract of the
leaves of B. orellana possesses antimicrobial activity against Gram (+) microorganisms
and C. albicans [7]. Also, its leaves have been employed to treat malaria and
leishmaniasis[8]. Its seeds contain carotenoids [9]. The ethanol extract of C. Peltata has
been used as an antibilious, cardiotonic and diuretic agent[10]. In addition, its leaves have
been employed against blennorrhea and warts[11,12]. The decoction of the leaves of C.
officinalis is used to treat amebiasis. Its dry bark is active against P. falciparum, and
herpes[13]. It contains quinoline alkaloids[14]. Branches and leaves of G. sepium are used
to reduce fever in children and adults. It has also been used as insecticide and to treat
infections produced by Microsporum canis, Trichophyton mentagrophytes, and Neisseria
gonorrohae [15]. Its leaves contain triterpene saponins (I and II)[16]. The water extract of J.
mimosifolia is active against P. aeruginosa. Its flowers contain flavones and flavonoids[17].
Its leaves have iridoids, triterpenes, flavones, and steroids[18]. J. secunda has been used to
disinfect scorpion wounds[19]. P. pulchrum is used to disinfect snakebites[20]. Other
species exhibit antimicrobial activity against P. aeruginosa andC.albicans [21].Polygala spp.
possesses trypanocidal activity[22,23]. It contains coumarins [24]. Flowers of S.
americana are used to treat mouth infections and some varieties of herpes. It contains
spilantol[25].
Evidently, there are not sufficient scientific studies that confirm the antimicrobial properties
of these plants. This study looks into the in vitro antimicrobial activity of these plants against
six pathogenic microorganisms that cause the most common cases of infectious diseases of
poverished communities in Colombia.
Other Sections▼
Methods
Plant material
All the plants were collected by farmers and traditional healers from the Andes and pacific
region of Colombia (Antioquia, Chocó and Huila departments). All the species were
identified by Professor Francisco Roldan (Instituto de Biología) in the Herbarium of the
Universidad de Antioquia (HUA). Voucher numbers and plant organs are shown in Table 1.
Preparation of plant extracts
The plant extracts were prepared using the modified method of Alade & Irobi [26]. Briefly,
three 100 g portions of the dried powdered plant were soaked separately in 500 ml of
distilled water, ethanol (98 %) and η-hexane (99 %), for 72 h. Then, each mixture was
refluxed followed by agitation at 200 rpm for 1 h. The filtrates obtained were concentrated
under vacuum at 40°C to obtain the dry extracts (Table 1). '[seeAdditional file 1]'.
Determination of antimicrobial activity
Microorganisms used
The test organisms (S. aureus ATCC 29737, S. β hemolític ATCC 10389, B. cereusATCC
14603, P. aeruginosa ATCC 25619, E. coli ATCC 10536, and C. albicansATCC 53324)
were obtained from the microbiology laboratory, College of Medicine of the Universidad de
Antioquia.
Culture media
The medium used for the activation of the microorganisms was soybean casein broth
(SBCB). The following selective agar media were used for the antimicrobial test: Baird-
Parker (S. aureus), Cetrimide (P. aeruginosa), McConkey (E. coli), Blood (S. β hemolitic),
Nutritive (B. cereus), and Saboraud-dextrose (C. albicans). All the culture media were
prepared and treated according to the manufacturer guidelines (Becton Dickinson® M.D.
USA).
Inoculum
The microorganisms were inoculated into SBCB and incubated at 35 ± 2°C for 4 h. The
turbidity of the resulting suspensions was diluted with SBCB to obtain a transmittance of
25.0 % at 580 nm. That percentage was found spectrophotometrically comparable to 1
McFarland turbidity standard. This level of turbidity is equivalent to approximately 3.0 ×
108 CFU/ml. The Bausch & Lomb®spectrophotometer, Model Spectronic 20 was used to
adjust the transmittance of the working suspensions.
Agar diffusion assay
The modified agar well diffusion method of Perez et al., [27] was employed. Each selective
medium was inoculated with the microorganism suspended in SBCB. Once the agar was
solidified, it was punched with a six millimeters diameter wells and filled with 25 μL of the
plants extracts and blanks (ethanol, distilled water, and hexane). The concentration of the
extracts employed was 25 μg/ml. Simultaneously, gentamycin sulfate (S. aureus, P.
aeruginosa, E. coli, and B. cereus), clindamycin (S. β hemolytic), and nystatin (C. albicans)
were used as positive controls at a concentration of 1.0, 0.3 and 1.0 μg/ml respectively. The
dilution medium for the positive controls was sterile distilled water. The test was carried out
by triplicate. The plaques were incubated at 35 ± 2°C for 24 h, except for C. albicans which
was incubated at 29 ± 2°C. The antimicrobial activity was calculated by applying the
expression:
Where RIZD is the percentage of relative inhibition zone diameter and IZD is the inhibition
zone diameter (mm). Equation (1) compensates the possible effect of the solvent (blank)
other than water on the IZD. The resulting IZD of the samples were either higher than or
equal to the IZD of the blanks. Therefore, the obtained percentages were positive (Table 1).
'[see Additional file table1]'. The test was considered negative (-) when the IZD of the
sample was equal to the IZD of the blank.
Minimal inhibitory concentration (MIC) evaluation
The MIC was evaluated on plant extracts that showed antimicrobial activity. This test was
performed at four concentrations of each extract (6.3, 12.5, 25, 50 μg/ml) employing the
same modified agar well diffusion method. Calculations of MIC were determined by
regression analysis using the software STATGRAPHICS® v. 4 (Table 2). '[see Additional file
table1]'.
Phytochemical screening
The method of Martinez & Valencia [28] was implemented to identify the general
phytochemical groups of compounds in the extracts (Table 1). '[see Additional file table1]'.
The test for amino acids was conducted by dissolving 10 mg of dry extracts in 1 ml of
ethanol and adding 1 droplet of ninhidrine reagent. For flavonoids, Shimoda's test was
adopted (15 mg of dry extract was dissolved in 1 ml of ethanol, concentrated HCl, and
magnesium turnins were added). Anthocyanins were identified by adding 1 ml of boiling
water, 0.5 ml of 37 % HCl to 10 mg of dry extract. The solution was heated at 100°C, cooled
and added 0.4 ml of amylic alcohol.
The test for phenolic compounds was carried out by dissolving 10 mg of dry extract in 1 ml
of 1 % ferric chloride solution. For tannins, 1 ml of the gelatin reagent was added to 1 ml of
the filtered aqueous extract. Quinones were identified by extracting 10 ml of the aqueous
extract with dichloromethane, evaporating the organic phase, and adding 5 ml of ethanol, 1
ml of hydrogen peroxide 5 % and 1 ml of sulfuric acid 50 % respectively. The solution was
heated, cooled, extracted with benzene and 1 ml of ammonia solution added.
Cardiac glycosides were identified by evaporating 1 ml of the organic phase, dissolving the
residue in 1 ml of ethanol and adding 0.5 ml of Kedde's reagent. For triterpenoids and
steroids, 0.5 ml of acetic anhydride and 1 droplet of 37 % sulfuric acid solution were added
to 0.5 ml of the organic phase. The test for alkaloids was carried out by adding 0.5 ml of the
aqueous extract into four test tubes; boiled, filtered and one droplet of the reagents of
Mayer, Valser, Dragendorff and ammonium Reineckate was added respectively.
Statistical analysis
All values are expressed as means ± standard deviation (Table 2). '[see Additional file
table1]'. The MIC data for each microorganism were analyzed using one-way analysis of
variance (ANOVA) and the differences among group means were analyzed using the
Dunnett's multiple comparisons test. P value < 0.05 was considered as significant. The
software MINITAB® was employed for the statistical analysis.
Other Sections▼
Results and discussion
All the plants showed antimicrobial activity in regards to at least three microorganisms
tested (Table 1). '[see Additional file table1]'. The ethanol extracts ofB. orellana (seeds), G.
sepium, J. mimosifolia and P. pulchrum were the most active against the microorganisms
studied. In some cases, the three extracts of the same plant had antimicrobial activity
against the same microorganism. For instance, the three extracts of J. mimosifolia were
active against B. cereus. This possibly means that the compound responsible for the
antimicrobial activity was present in each extract at a different concentration.
All the plants exhibited different kinds of secondary metabolites. In particular, J.
mimosifolia presented the highest yield of extractable substances in the water extract
(15.0%). This result indicates that decoction is a good method to extract anthocyanins,
phenolic compounds, and alkaloids found in this species. These compounds could be
responsible for its antimicrobial activity against B. cereus andE. coli. Former studies of the
water extract revealed antimicrobial activity against P. aeruginosa [17]. However, we did not
find antimicrobial activity against this pathogenic microorganism. Furthermore, the water
extract of J. mimosifolia, and P. pulchrum showed a higher activity (compared to the
gentamycin sulfate) against B. cereus. The water extract of P. pulchrum also showed
antimicrobial activity againstS. aureus.
Ethanol extracts exhibited a higher degree of antimicrobial activity as compared with water
and hexane extracts fractions. This finding is correlated with the medicinal preparations that
use rum and liquor to extract the active plant components.
E. coli, B. cereus and S. aureus were the most susceptible bacteria to all plant extracts. On
the contrary, S. β hemolytic, P. aureginosa and C. albicans were the most resistant
microorganisms. None of the extracts was more active against S. βhemolytic than the
positive control (clindamycin). Likewise, the ethanol extract of J. secunda was the only
extract active against P. aeruginosa. Only three plants (J. secunda, P. pulchrum and P.
paniculata) were the most active against C. albicans. This result is in accord with formers
studies executed on Piper spp. [21].
Steroids and anthocyanins of B. orellana (seeds) could be responsible for their antimicrobial
activity against S. aureus, B. cereus and E. coli. Similarly, the presence of steroids and
amino acids in C. peltata could correspond to its high antimicrobial activity exhibited
against E. coli. B. pilosa showed a low activity against S. aureusand B. cereus. However,
some studies established that the methanol extract of this plant is highly active against S.
aureus, S. epidermidis and B. subtilis [29].
C. officinalis was the species that exhibited the greatest variety of secondary metabolites. It
also showed antimicrobial activity against all the pathogens studied. Similarly, S.
americana presented antimicrobial activity against all the microorganisms studied except
for C. albicans. Alkaloids and steroids found in this plant might account for this. Former
studies associated the alkaloid spilantol with its biological activity [21]. This plant also
showed the lowest yield of extractable solids among all the plants (0.02%).
Table 2 shows that J. secunda and P. pulchrum presented similar MICs against C.
albicans (0.5 and 0.6 μg/ml, respectively) compared to nystatin (0.6 μg/ml). Moreover, these
two plants manifested a better MIC against E. coli (0.6 μg/ml) than gentamycin sulfate (0.9
μg/ml). However, there was no statistical difference between MICs of seven plants and
gentamycin sulfate. J. secunda and B. orellana were the only plants that exhibited a similar
MIC against P. aeruginosa (1.3 and 4.8 μg/ml) compared to gentamycin sulfate (0.3 μg/ml).
B. orellana L, J. secunda and P. pulchrum presented the lowest MICs against E. coli(0.8,
0.6 and 0.6 μg/ml, respectively) compared to gentamycin sulfate (0.9 μg/ml). Likewise, B.
orellana manifested the lowest value of MIC against B. cereus (0.2 μg/ml) compared to
gentamycin sulfate (0.5 μg/ml). However, for B. cereus there was no statistical difference
between MICs of eight plants and gentamycin.
Other Sections▼
Conclusion
All the extracts showed varying degrees of antimicrobial activity on the microorganisms
tested. Some of these plants were more effective than traditional antibiotics to combat the
pathogenic microorganisms studied. The chance to find antimicrobial activity was more
apparent in ethanol than water extracts of the same plants. Three species (B. orellana, J.
secunda and P. pulchrum presented the lowest MIC compared to the antibiotic standard.
These plants could be a source of new antibiotic compounds. Further work is needed to
isolate the secondary metabolites from the extracts studied in order to test specific
antimicrobial activity.
This in vitro study demonstrated that folk medicine can be as effective as modern medicine
to combat pathogenic microorganisms. The millenarian use of these plants in folk medicine
suggests that they represent an economic and safe alternative to treat infectious diseases.
However, none of the plants are recommended in the treatment of infections produced by S.
β hemolitic and P. aeruginosa.
Other Sections▼
List of abbreviations
ATCC – American Type Culture Collection
B. cereus – Bacillus cereus
B. pilosa – Bidens pilosa L
B. subtilis – Bacillus subtilis
B. orellana – Bixa orellana L.
C. albicans-Candida albicans
C. peltata – Cecropia peltata L.
C. officinalis – Cinchona officinalis L.
E. coli – Escherichia coli
G. sepium – Gliricidia sepium H.B. & K
J. secunda – Justicia secunda Vahl
J. mimosifolia – Jacaranda mimosifolia D.Don
P. aeruginosa – Pseudomonas aeruginosa
P. pulchrum – Piper pulchrum
P. paniculata – Polygala paniculata L.
SBCB-Soybean casein broth
S. β hemolitic – Streptococcus β hemolític
S. aureus – Staphylococcus aureus
S. epidermidis – Staphylococcus epidermidis
S. americana – Spilanthes americana Hieron
Competing interests
The author(s) declare that they have no competing interests.
Authors' contributions
JJR conceived and designed the study, performed the MIC tests, analyzed the data
obtained and drafted this paper. JFM and SAO interviewed local healers and farmers; they
also performed the phytochemical screening and the antimicrobial tests. VJO Participated in
the extraction, susceptibility testing and analysis of data. All authors read and approved the
final manuscript.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1472-6882/6/2/prepub
Supplementary Material
Additional file 1
Table 1 – Antimicrobial activity and phytochemicals screening of the plants studied. Table 2
– Minimum Inhibitory Concentration of the plants studied.
Click here for file(53K, rtf)
Acknowledgements
The authors acknowledge the assistance of the technicians Johny Sánchez, Gloria A.
Valencia, and Jorge Arango. We also acknowledge local healers for their assistance in
finding the plant species. Similarly, we acknowledge Professor Francisco Roldán for
assisting us with the identification of plant materials. We thank Professor Carol Severino for
checking the language and style of this manuscript. This work was supported by grants from
the Pharmacy department of the Universidad de Antioquia.
Other Sections▼
References
1. Gonzalez J. Medicinal plants in Colombia. J Ethnopharmacol. 1980;2:43–47. doi: 10.1016/0378-
8741(80)90029-X. [PubMed] [Cross Ref]
2. Ospina S, Arbeláez MP, Paniagua LA, Peláez MC, Ramírez JC, Sánchez LC, Tuiran V, Villegas CE.
Factores de riezgo para infección intrahospitalaria por bacterias multiresistentes a los
antibioticos. Enfermedades infecciosas y microbiologia Infecciones nosocomiales.2002;22:127.
3. Shah PM. The need for new therapeutic agents: what is in the pipeline? Clinical Microbiology and
Infection. 2005;11:36–42. doi: 10.1111/j.1469-0691.2005.01141.x. [PubMed] [Cross Ref]
4. Fabricant DS, Farnsworth NR. The value of plants used in traditional medicine for drug
discovery. Environmental Health Perspectives Supplements. 2001;109:69–75.
5. Bondarenko AS, Petrenko GT, Aizenman BE, Evseenko OV. Antimicrobialproperties of phenylheptatriyne, a
polyacetylene antibiotic. Mikrobiologicheskii Zhurnal. 1985;47:81–83.[PubMed]
6. Brandao MGL, Krettli AU, Soares LSR, Nery CGC, Marinuzzi HC. Antimalarial activity of extracts and
fractions from Bidens pilosa and Bidens species (Asteraceae) correlated with the presence of acetylene and
flavonoid compounds. J Ethnopharmacol. 1997;57:131–138. doi: 10.1016/S0378-8741(97)00060-
3. [PubMed] [Cross Ref]
7. Fleischer TC, Ameade EPK, Mensah MLK, Sawer IK. Antimicrobial activity of the leaves and seeds of Bixa
orellana. Fitoterapia. 2003;74:136–38. doi: 10.1016/S0367-326X(02)00289-7.[PubMed] [Cross Ref]
8. Irobi ON, Moo-Young M, Anderson WA. In vitro clonal propagation of annatto (Bixa orellana L.)Pharm
Biol. 1996;34:87.
9. Kiokias S, Gordon MH. Antioxidant properties of annatto carotenoids. Food Chem.2003;83:523–529. doi:
10.1016/S0308-8146(03)00148-1. [Cross Ref]
10. Caceres A, Lopez BR, Giron MA, Logemann H. Plants used in guatemala for the treatment of dermatophytic
infections. 1. Screening for antimycotic activity of 44 plant extracts. J Ethnopharmacol. 1991;31:263–409.
doi: 10.1016/0378-8741(91)90011-2. [PubMed][Cross Ref]
11. Vásquez ML. Plantas y frutas medicinales de Colombia y América. 1. Bogota: Climent; 1982. Cecropia; pp.
134–135.
12. Hikawczuk J, Saad V, Guardia T, Juarez AO, Giordano OS. Anti-inflammatory activity of compounds
isolated from Cecropia pachystachya. Anales de la Asociacion Quimica Argentina. 1998;86:167–170.
13. Warhurst DC. Cinchona alkaloids and malaria. Lancet. 1981;2:1346–1347. doi: 10.1016/S0140-
6736(81)91364-7. [PubMed] [Cross Ref]
14. Wijesekera OB, Rajapakse LS, Chelvarajan DW. A simple thin-layer chromatographic method for separation
of cinchona alkaloids. J Chromatogr. 1976;A21:388–389. doi: 10.1016/S0021-9673(00)85038-
4. [PubMed] [Cross Ref]
15. Gupta MP. 270 Plantas Medicinales Iberoamericanas. 1. Bogota: Presencia Ltda; 1995. Gliricidia sepium;
pp. 378–379.
16. Rastrelli L, Caceres A, De Simone F, Aquino R. Studies on the constituents of Gliricidia sepium
(Leguminosae) leaves and roots: Isolation and structure elucidation of new triterpenoid saponins and
aromatic compounds. J Agric Food Chem. 1999;47:1537–1540. doi: 10.1021/jf9808731. [PubMed] [Cross
Ref]
17. Binutu OA, Lajubutu B. antimicrobial potentials of some plant species of the Bignoniaceae family. Afr J Med
Med Sci. 1994;23:269. [PubMed]
18. Gambaro V, Garbarino JA, Galeffi C, Nicoletti M, Messana I, Marini-Bettolo GB. Constituents of Jacaranda
mimosaefolia. Rev Lat Quim. 1988;19:17–19.
19. Lans C, Harper T, Georges K, Bridgewater E. Medicinal and ethnoveterinary remedies of hunters in
Trinidad. BMC complementary and alternative medicine. 2001;1:1–10. doi: 10.1186/1472-6882-1-10. [PMC
free article] [PubMed] [Cross Ref]
20. Otero R, Nunez V, Barona J, Fonnegra R, Jimenez SL, Osorio RG, Saldarriaga MDA. Snakebites and
ethnobotany in the northwest region of Colombia. Part III: neutralization of the haemorrhagic effect of
Bothrops atrox venom. J Ethnopharmacol. 2000;73:233–41. doi: 10.1016/S0378-8741(00)00321-
4. [PubMed] [Cross Ref]
21. Oyedeji OA, Adeniyi BA, Ajayi O, Konig WA. Essential oil composition of Piper guineense and its
antimicrobial activity. Another Chemotype from Nigeria. Phytother Res. 2005;19:362–364. doi:
10.1002/ptr.1679. [PubMed] [Cross Ref]
22. Pizzolatti MG, Koga AH, Grisard EC, Steindel M. Trypanocidal activity of extracts from Brazilian Atlantic
Rain Forest plant species. Phytomedicine: international journal of phytotherapy and
phytopharmacology. 2003;10:422–426. [PubMed]
23. Bader G, Kulhanek Y, Ziegler-Boehme H. Antifungal action of glycosides of polygalacic
acid.Pharmazie. 1990;45:618–20. [PubMed]
24. Hamburger M, Gupta M, Hostettmann K. Coumarins from Polygala paniculata. Planta Medica.1985;3:215–
217. [PubMed]
25. Ospina LS, Olarte J, Nuñez E. Phytopharmacological studies on a liposoluble fraction of Spilanthes
americana (Mutis) flowers. Part I. Phytochemical studies. Rev Colomb Cienc Quim Farm. 1986;15:37.
26. Alade PI, Irobi ON. Antimicrobial activities of crude leaf extracts of Acalypha wilkensiana. J
Ethnopharmacol. 1993;39:171–174. doi: 10.1016/0378-8741(93)90033-2. [PubMed][Cross Ref]
27. Perez C, Pauli M, Bazevque P. An antibiotic assay by the agar well diffusion method. Acta Biologiae et
Medicine Experimentalis. 1990;15:113–115.
28. Martinez A, Valencia G. Manual de prácticas de Farmacognosia y Fitoquímica: 1999. 1. Medellin:
Universidad de Antioquia; 2003. Marcha fitoquimica; pp. 59–65.
29. Rabe T, Van J. Antibacterial activity of South African plants used for medicinal purposes. J
Ethnopharmacol. 1997;56:81–87. doi: 10.1016/S0378-8741(96)01515-2. [PubMed][Cross Ref]
Antibacterial activity and phytochemical study of six medicinal plants used in Benin.Anago E, Lagnika L, Gbenou J, Loko F, Moudachirou M, Sanni A.
Source
Laboratory of Biochemistry and Molecular Biology, Institute des Sciences Biomédicales Appliquées (ISBA), University of
Abomey-Calavi, Cotonou, Republic of Benin.
AbstractThe ethanol extracts obtained from Psidium guajava, Flacourtia flavescens Boswellia dalzielii, Ficus exasperata, Pavetta corymbosa and Hybanthus enneaspermus, six species traditionally used in Benin to treat several infectious diseases, were evaluated for their in vitro antimicrobial activity against Staphylococcus aureus, Enteroccocus feacalis, Escherichia coli and Pseudomonas aeruginosa. The minimum inhibitory concentration of extracts was determinate using the microplate dilution method. The presence of major phytoconstituents was detected qualitatively. The diphenylpicrylhydrazine radical scavengingactivity was also performed. The extracts exhibited antibacterial activities against the tested bacteria. Boswellia dalzielii,Psidium guayava, Pavetta corymbosa and Flacourtia flavescens exibited the lowest minimum inhibitory concentration values (0.313-2.5 mg mL(-1)). Pseudomonas aeruginosa was the lest sensitive microorganism with MIC values higher than 10 mg mL(-1). In antioxidant assay the crude extracts of B. dalzielii and P. corymbosa appeared to be as potent as quercetol with an inhibition percentage of 83 and 75.3% at 10 microg mL(-1) which is comparable to 75.9% for quercetol at the same concentration.
In-vitro antibacterial activity of selected medicinal plants from Longisa region of Bomet district, KenyaK R Cheruiyot, D Olila, and J KatereggaDepartment of Physiological Sciences, Faculty of Veterinary Medicine, Makerere University, P. O Box 7062, Kampala-UgandaCorresponding author Cheruiyot K. R Email: [email protected], [email protected], Mobile Number: +254724601814
Other Sections▼
Abstract
Background
Current strategies to overcome the global problem of antimicrobial resistance include
research in finding new and innovative antimicrobials from plants. This study was carried
out to determine the antibacterial activity of plant extracts of Olea africanastem-
bark, Psidium guajava leaves, Vernonia amygdalina leaves, Lantana camaraleaves
and Mangifera indica leaves which are used in folklore medicine to treat infections of
microbial origin in Longisa region of Bomet District, Kenya.
Methods
Methanol extracts were derived and screened. Standard cultures of Escherichia coliATCC
25922, Pseudomonas aeruginosa ATCC 27853, and Staphylococcus aureusATCC 25923
were used in the study. The antibacterial tests used were the agar well diffusion assays at
concentration 1gm/ml. Minimum Inhibition Concentration (MIC) was determined in the plant
extract that showed some efficacy against the tested microorganisms. Gentamicin (10µg)
was used as a positive control.
Results
The methanol extracts showed weak antibacterial activity against the study organisms
compared to Gentamicin. All extracts exhibited a significant bactericidal activity against S.
aureus while L. camara and V. amygdalina lacked efficacy againstP.aeruginosa and E. coli.
O. africana and P. guajava presented the lowest MIC against S.aureus (62.5 mg/ml and 250
mg/ml respectively P.guajava and M. indicashowed analogous MICs
against P.aeruginosa (250 mg/ml). P.guajava exhibited a better MIC against E.coli (500
mg/ml).
Conclusions
This in-vitro study corroborated the antimicrobial activity of the selected plants used in
folklore medicine. The plants could be potential sources of new antimicrobial agent.
Key words: Medicinal Plant extracts, antibacterial activity, MIC
Other Sections▼
Introduction
Many works have been done which aim at knowing the different antimicrobial and
phytochemical constituents of medicinal plants and using them for the treatment of microbial
as possible alternatives to chemically synthetic drugs to which many infectious
microorganisms have become resistant. Moreover, antibacterial pharmaceuticals are not
accessible to the majority of the communities in the developing countries1. Increase in
resistance calls for new antibacterial drugs, one source of which are traditional medicinal
plants. Plants may provide natural source of antimicrobial drugs that will/or provide novel or
lead compounds that may be employed in controlling some infections globally.
Olea africana (Oleaceae) is a tree of about 3–15 m in height, may assume bushy habit if
stunted. Leaf or Stem bark are used to treat sore throat, kidney problems, backache, colic
or urinary tract infections. Olea africana has been demonstrated scientifically possessing;
antimicrobial activity, antiarrhythmic activity, diuretic activity, anti-inflammatory activity and
hepatic activity 2. Phytochemical tests in laboratories indicated the presence of alkaloids,
saponins and tannins, but not of cardiac or cyanogenic glycosides. Psidium guajava L
(Myrtaceae) is a native plant of tropical America. Different parts of the plants are used in
treatment of various human aliments such as wounds, ulcers, bowels and cholera.
Pharmacological investigations indicated that its bark, fruit, and leaves possess,
hypoglycemic, anti-inflammatory, analgesic, antipyretic, spasmolytic, CNS depressant and
antimicrobial activities. The leaves of P. guajava contain an essential oil rich in cineol,
tannins, triterpenes and flavonoids3–5. Vernonia amygdalina (Compositae) is a shrub, of 2–5
m tall with petiolate green leaves of about 6 mm diameter. The roots and the leaves are
used in ethno medicine to treat fever, hiccups, kidney problems, stomach discomfort and
bacterial infections6. The active components of the plant have been shown to be mainly
sesquiterpene lactones like vernodalin and vernoamygdalin and steroid glycosides like
vernonioside B1 and vernoniol B7. Lantana camara Linn.(Verbenaceae) is a rugged
evergreen strong-smelling herb, native of tropical America, but now naturalized in many
parts of Africa. All the parts of this plant have been used traditionally for several ailments
throughout the world. The leaves are used as a bechic, antitumoral, antibacterial and
antihypertensive agent8. The root of this plant is used for the treatment of malaria,
rheumatism and skin rashes9.Mangifera indica (Anacardiaceae) is a large evergreen tree,
with a heavy, dome-shaped crown. It is found all over the tropical regions of the world
where it is used as a horticultural and medicinal plant. The use of leaf extracts as
antimicrobial in the treatment of burns, scalds, sores, wounds, abscesses and other
infections in humans and animals has been reported in a number of ethnobotanical
surveys10. The leaves have been reported to contain saponins, glycosides, unsaturated
sterols, polyphenols, euxanthin acid, mangiferine, mangin, gallic tannins11. This study looks
into the in vitro antibacterial activity of these plants against three pathogenic
microorganisms (Staphylococus aureus, Pseudomonas aeruginosa and Escherichia coli)
that cause the most common cases of infectious diseases of poverished communities in
Bomet District. Qualitative phytochemical screening of alkaloids, tannins, flavonoids,
anthraquinones, saponins, glycoside or cardiac glycosides was carried out using standard
methods 12, 13.
Other Sections▼
Materials and method
Plant collection and Identification
Ethno pharmacological information of several medicinal plants was sourced from
literatures14, 15 and through consultation from elderly people in age bracket of above 50 years
from Siwot Village, Longisa division in Bomet district, Kenya, during the month of January
2008. Plants selected for study was obtained by ranking basing on diseases they treated,
frequency of their use and their availability. Taxonomic identity of voucher specimen was
done by comparing with those of known identity in the Makerere University herbarium in
Kampala.
Processing and Extraction of Plant Material
The plant parts were chopped and shade-dried at room temperature for 2 weeks then
grounded using metallic mortar and pestle to a fine powder for ease of extraction of active
compounds. The grounded samples were then transported for extraction process at the
Pharmacology Laboratory of Faculty of Vet medicine, Makerere University. The grounded
powder were weighed on Satorius balance type BA 610, soaked in known volumes of 95 %
Analytical Methanol and allowed to stand for two days with intermittent shaking. Filtration
through cotton wool was done to remove coarse particles and finely through filter paper
(Whatman® No.1, England) in Buchner funnel. This was followed by concentration on
Rotavapour type Buchi-R-Switzerland at 50 °C to recover the solvent used. Extracts were
dissolved in small drops of Dimethyl sulfoxide (DMSO) and toped up with Physiological
saline and the stock solution kept at 4 °C.
Preparation of the test micro-organisms
This process followed the previously established procedures for testing antimicrobial
agents. Standard cultures of bacteria from the American Type Culture Collection were
obtained from the Microbiology Laboratory,Faculty of Veterinary Medicine of Makerere
University. A Gram positive bacterium; Staphylococcus aureus ATCC 25923, was used as a
wound/skin pathogen and Gram negative bacteria;Escherichia coli ATCC 25922, was used
to represent pathogens that cause gastro enteritis while Pseudomonas aeruginosa ATCC
27853, was used as an environmental pathogen16. Standardized bacterial suspension was
prepared by picking a colony of respective bacteria using sterile wire loop and suspending it
in 5 ml Brain heart infusion liquid media. The dilutions formed the bacterial stock solutions
for use in the agar-well diffusion assays.
Preparation of culture media
Mueller Hinton agar (Becton Dickinson ® M.D USA) was used for direct sensitivity testing.
The media was prepared and treated according to manufacturer's guidelines. Thirty five
(35) g medium was mixed with one litre of distilled water, enclosed in a screw cap container
and autoclaved at 121 °C for 15 minutes. The medium was later dispensed into 90 mm
sterile agar plates and left to set. The agar plates were incubated for 24 hours at 37 °C to
confirm their sterility. When no growth occurred after 24 hours, the plates were considered
sterile.
Agar-Well Diffusion Assay
A concentration of 1 g/ml of the plant extracts was designed from the stock solution for agar
well diffusion assay. Cultures of S.aureus, E.coli and P.aeruginosa were inoculated
separately on the surface of Mueller Hinton agar plates by surface spreading using a sterile
cotton swab and each bacterium evenly spread over the entire surface of agar plate to
obtain a uniform inoculum. The sensitivity testing of the plant extracts was done using the
agar well diffusion method17 whereby, wells of 6 mm diameter and 5 mm depth were made
on the solid agar using a sterile glass borer. About 50 µl of the methanol extract, of the
concentration 1 g/ml, was dispensed into respective wells and 10 µg Gentamycin was used
as a positive control since it is a broad spectrum antibiotic. Physiological saline/Dimethyl
sulfoxide (DMSO) was used as negative control. All the tests were run in triplicates for
quality results. The set up was incubated for 24 hours at 37 °C. Twenty four (24) hours later,
the zones of inhibition were measured using a ruler (AIM®) and a pair of divider then results
reported in millimeters (mm).
Minimum Inhibition Concentration (MIC) Evaluation
The MIC was evaluated on plant extracts that showed antibacterial activity in the agar well
diffusion assay on any organism. This test was performed at five concentration of each
extract (500 mg/ml, 250 mg/ml, 125 mg/ml, 62.5 mg/ml and 31.25 mg/ml) employing
doubling dilutions of plant extract in Brain heart infusion broth up to the fifth dilution. One (1)
ml of the resultant broth was put in test tube and equal amounts of the extracts (1 ml) were
added to the first test tube and serial dilution done with the last 1 ml being discarded. To
complete the test, each organism was separately suspended in 5 ml of Brain heart infusion
broth and incubated overnight, after which 0.1 ml was added to all the test tubes and
preparation incubated at 37 °C for 18 hours. After incubation, a loop full from each tube was
sub cultured on nutrient agar to see if bacteria growth was inhibited (Minimum Bactericidal
Activity). Growth of bacteria on solid media indicated that particular concentration of the
extract was unable to inhibit the bacteria. The MIC was defined as the lowest concentration
of an antimicrobial that inhibited the visible growth of a microorganism after overnight
incubation 18.
Qualitative Phytochemical analysis of the plant extract
This was a qualitative analysis done at the department of Botany Laboratory, Faculty of
Science, Makerere University. A small portion of the extract was used for phytochemical
screening test. Alkaloids, Saponins, Tannins, Flavonoids, Glycosides, Cardiac glycosides
and Anthraquinones was carried out using standard methods12,13
Data Analysis
Microsoft Excel® was used to enter and capture data. Various graphs and tables were
extracted from this data. Data was then exported to SPSS for further analysis. The MIC for
each microorganism was analyzed using one-way analysis of variance (ANOVA). P value <
0.05 was considered as significant. SPSS 15.0 was employed for statistical analysis.
Other Sections▼
Results and discussion
Qualitative phytochemical screening indicated that the methanol plant extracts contained
classes of compounds as shown in Table 1. All plants exhibited different kinds of secondary
metabolites. This probably contributed to their antibacterial activity. All extracts showed
presence of Tannins and Flavonoids as seen in Table 1.Mangifera indica Contained all
screened metabolites except Cardiac Glycosides. This result is in accord with former
studies executed on the M. indica ethanol extract of its leaves 10. The bioactive ingredients
could be responsible for antibacterial activity of the plant extracts. Tannins have been found
to form irreversible complexes with proline-rich proteins resulting in the inhibition of the cell
protein synthesis. This activity was exhibited by Mangifera indica and Psidium
guajava against test organisms19. Previous studies show that secondary plant metabolites
constitute an important source of microbicides, pesticides and many pharmaceutical
drugs20, 21.
Table 1Classes of Bioactive compounds identified in the Methanol plant extract
The results showed that plant extracts demonstrated antibacterial activity against
theS.aureus, E.coli and P.aeruginosa. It can be noted from Figure 1 thatStaphylococcus
aureus was the most susceptible of the three organisms and E.colithe least. All the plant
species showed activity against Staphylococcus aureus (Fig 1). Psidium guajava had the
highest zone of inhibition to the other extracts (19.7 mm) against S.aureus, while Olea
africana had the least MIC (62.5 mg/ml) againstS.aureus signifying higher activity. From the
three methanol extracts with activities against E.coli, Psidium guajava was the most active
with a Zone of inhibition of 16 mm and an MIC of 500 mg/ml. This was followed
by Mangifera indica (13 mm), with an MIC of 1000 mg/ml and lastly Olea africana with a
zone of inhibition of 8.3 mm and an MIC of 1000 mg/ml. The most active methanol plant
extract from the study againstPseudomonas aeruginosa was Mangifera indica with a Zone
of Inhibition of 17 mm and an MIC of 250 mg/ml, followed by P.guajava (16 mm) with an
MIC of 250 mg/ml. This was followed by Olea africana with a Zone of Inhibition of 9.8 mm
and an MIC of 1000 mg/ml. The most active methanol plant extract on Staphylococcus
aureus wasPsidium guajava with a zone of inhibition of 19.7 mm and an MIC of 250 mg/ml,
followed by Olea africana and Mangifera indica both with analogous zone of inhibition (18.5
mm) and a better MIC of 62.5 mg/ml and 500 mg/ml respectively. Lastly wereVernonia
amygdalina and Lantana camara both with zone of inhibition of 17 mm and an MIC of 1000
mg/ml. Escherichia coli showed resistance to Vernonia amygdalinaand Lantana
camara while Pseudomonas aeruginosa was resistant to Vernonia amygdalina. According
to statistical analysis results of one way ANOVA ofStaphylococcus aureus the P-value was
0.306, F- calculated was 2.5 and F-critical was 19.2, one way ANOVA for Pseudomonas
aeruginosa; P-value was 0.808, F-calculated was 0.225 and F-critical was 6.94. Lastly one
way ANOVA for Escherichia coli P-value was 0.530, F-calculated 0.455 and F-critical 6.61.
Since P-values were greater than 0.05 (P >0.05). Hence, we fail to reject the null hypothesis
and conclude that there is no significant variation in the MIC at 95% confidence Interval for
each of the test organisms.
Fig 1Chart showing the Zone of inhibition of Plant Methanol Extract
The zones of inhibition produced by the test organisms indicated their susceptibility to the
plant extracts; it was observed that the zones of inhibition varied from one organism to
another and from one plant part extract to another. According to Prescott22 the effect of an
agent varies with target species. The effective use ofP.guajava in diarrhea, dysentery and
gastroenteritis can be related to guava's documented antibacterial properties. Bark and leaf
extracts have shown to have in vitro toxic action against numerous bacteria. In several
studies guava showed significant antibacterial activity against such common diarrhea-
causing bacteria asStaphylococcus, Shigella, Salmonella, Bacillus, E. coli, Clostridium, and
Pseudomonas (3–5). Olea africana had the least MIC (62.5 mg/ml)
against S.aureussignifying higher activity in this study. The plant showed broad spectrum
activity against the tested organisms. This justified the use of plant in treatment of infections
of microbial origin2. Vernonia amygdalina lacked efficacy against P. aeruginosa.
Also, Vernonia amygdalina and Lantana camara extracts did not have measurable activity
against E.coli. These observations are likely to be the result of the differences in the cell
wall structure between gram-negatives and gram-positive bacteria, with gram-negative
outer membrane acting as a barrier to many environmental substances, including
antibiotics23.
Vernonia amygdalina showed no activity against E.coli and P.aeruginosa thus indicating its
narrow spectrum of activity according to the study. A similar study was carried out to
determine the antibacterial potential of V. amygdalina using a panel multidrug resistant
gram-negative and gram-positive bacteria and standard strains:E. coli ATCC 25922
and Staphylococcus aureus ATCC 25923. Aqueous extract of V. amygdalina leaves was
found to produce growth inhibitory zones of 15.6 to 16.1 mm for E. coli and 12.1–12.3 mm
for S.aureus while two out of the eight Pseudomonas aeruginosa isolates tested showed
susceptibility (inhibitory zone diameter of 6.7+0.2 mm) to V. amygdalina by agar well
diffusion only. This result was in contrary to our results and indicated that water could be the
ideal solvent for extraction24. Lantana camara showed activity against Staphylococcus
aureus and was inactive againstE.coli. Related studies on Lantana camara root-bark
prepared with solvents of different polarity, was evaluated by the agar-well diffusion method.
Twelve bacteria, six each of gram-positive and gram-negative strains, were used in the
study. The activity of the chloroform and methanol extracts of L. camara was found to be
more specific towards the gram-positive strains, although gram-negative P. aeruginosawas
also inhibited by the methanol extracts of the plant in a dose dependent manner. The water
extracts of L. camara was found to be inactive25.
In conclusion Methanol extracts of the plant parts showed antibacterial activity against
disease-causing organisms and this suggest that constituents of the plants could be useful
in chemotherapy. From the findings od this study, the following recommendations could be
made; Firstly, there is a need to further isolate the active antibacterial agent (s) and
secondly, it is necessary to determine toxicity of the active constituents, their side effects
and pharmacokinetics effects.
Acknowledgement
I would like to acknowledge my supervisors, Associate prof. Deo Olila and Dr. John
Kateregga, for their professional guidance. Thanks go to my parents, Mr & Mrs. Mutai, for
their support always during research work and all Laboratory technicians and Technologist
for their technical support.
Other Sections▼
References
1. World Health Organisation, author. Global strategy for containment of antibiotic resistance.Geneva: WHO; 2001. p.
99.
2. Anesini C, Perez C. Screening of plants used in Argentinian folk medicine for antimicrobial activity.Journal of
Ethnopharmacology. 1993;39(2):119–128. [PubMed]
3. Olajide O A, Awe S O, Makinde J M. Pharmacological studies on the leaf of Psidium
guajava.Fitoterapia. 1999;70:25–31.
4. Begum S, Hassan S I, Siddiqui B S, Shaheen F, Ghayur M N, Gilani A H. Triperpenoids from the leaves
from Psidium guajava. Phytochemistry. 2002;61:399–403. [PubMed]
5. Gonçalves FA, Andrade Neto M, Bezerra JN, Macrae A, Sousa OV, Fonteles-Filho AA, et al. Antibacterial activity
of GUAVA, Psidium guajava Linnaeus, leaf extracts on diarrhea-causing enteric bacteria isolated from Seabob
shrimp, Xiphopenaeus kroyer (Heller) Rev Inst Med Trop Sao Paulo.2008;50(1):11–15. [PubMed]
6. Banso A, Adeyemo SO, Jeremiah P. Antimicrobial properties of Vernonia amygdalina extract. J Applied Sci
Magt. 1999;3:9–11.
7. Kupcham SM, Hernichway RJ, Wermer D. Vernodalin and Vernomygdin. Two new sesquiterpene lactones
from Vernonia amygdalina del. J Org Chem. 1969;3:3908–3909.
8. Taoubi K, Fauvel MT, Gleye J, Moulis C. Phenylpropanoid glycosides from Lantana camara andLippia
multiflora. Planta Med. 1997;63:192–193. [PubMed]
9. Chharba SC, Mahunnah RLA, Mshiu EN. Plants used in traditional medicine in eastern Tanzania. J
Ethnopharmacol. 1993;39:83–103. [PubMed]
10. Odyek O, Bbosa G S, Waako P, Kyegombe D B, Bukenya-Ziraba R, Ogwal-Okeng J. Antibacterial activity
of Mangifera indica (L.) African Journal of Ecology, Afr J Ecol. 2007;45(Suppl 1):13–16.
11. Ngo T. Contribution to researches on mango leaves raw materials in northern Vietnam. Science Technological
Publish. 2001:563–565.
12. Harbone JB. Phytochemical Methods. A Guide to Modern Techniques of plant Analysis. 3rd edition. Newyork:
Chapman and Hall; 1998. pp. 1–198.
13. Evans WC. Trease and Evans Pharmacognosy. 14th edition. WB Saunders Company Limited; 1998. pp. 15–16.
14. Iwu MM. Handbook of African Medicinal Plants. Boca Raton: CRC Press Inc.; 1993. pp. 223–225.
15. Dweck AC. Article for cosmetics & toiletries magazine ethnobotanical plants from Africa. Iltshire, UK: Black
Medicare Ltd; 2001. Available from: URL: http://www.dweckdata.co.uk/
16. Carter G R, Cole J R. Diagnostic Procedures in Vet. Bacteriology and Mycology. 5th Edn. London and Newyork:
Academic Press, Inc; 1990.
17. Irobi ON, Moo-Young M, Daramola SO. In J Pharmacognosy. 1996;34(2):87–90.
18. Andrew JM. Determination of MIC. Journal of Antimicrobial Chemotherapy. 2001;48(Suppl 1):5–16. [PubMed]
19. Subhuti Dharmananda. Gallnuts and the Uses of Tannins in Chinese Medicine. 2003. A paper delivered at
Institute for Traditional Medicine, Portland, Oregon.
20. Ibrahim MB, Owonubi MO, Onaopo JA. Antibacterial effect of extract of leaf, stem and roof bark of Anogeissus
leiocarpus on some bacterial organisms. J Pharm Res Dev. 1997;2(1):20–23.
21. Kolapo AL, Ogundiya MO, Okunade MB. Antimicrobial activities of some Nigerian chewing stick.2007. Available
from: URL: http://www.siu.odu/webl/leaflets/ogun diya hfm.
22. Prescott LMH, arley JP, Klein D. Microbiology (International Edition) Fifth edition. Mc Graw Hill Book Company;
2002. pp. 809–819.
23. Tortora GJ, Funke BR, Case CL. Microbiology: An introduction. San Franscisco: Benjamin Cummings; 2001.
24. Iwalokun B A, Bamiro S B, Durojaiye O O. An antimicrobial evaluation of Vernonia amygdalina(Compositae)
against gram-positive and gram-negative bacteria from Lagos, Nigeria. West African Journal of Pharmacology and
Drug Research. 2004;19
25. Basu Subhalakshmi, Ghosh Abhijit, Hazra Banasri. Evaluation of the antibacterial activity ofVentilago
madraspatana Gaertn., Rubia cordifolia Linn. and Lantana camara Linn.: isolation of emodin and physcion as active
antibacterial agents. Calcutta: Department of Pharmaceutical Technology, Jadavpur University; 2002. 700 032, India.
Fig 1
Chart showing the Zone of inhibition of Plant Methanol Extract
Table 1Classes of Bioactive compounds identified in the Methanol plant extract
Compound O. africana P.guajava V.amygdalina L.camara M.indica
Alkaloids ++ − ++ + ++
Tannins + ++ + + +
Saponinns − + − + +
Flavonoids + ++ + + ++
Anthraquinones − NT − − +
Glycosides − + − − ++
Cardiacglycosides NT − − + −Key: NT; Not tested, ++; strongly positive, +; positive, −; Negative
Inhibitory and Bactericidal Potential of Crude Acetone Extracts of Combretum molle (Combretaceae) on Drug-resistant Strains of Helicobacter pyloriCollise Njume,1 Anthony J. Afolayan,2 Amidou Samie,3 and Roland N. Ndip 1,4
1Microbial Pathogenicity and Molecular Epidemiology Research Group, Department of Biochemistry and Microbiology, University of Fort Hare, P/Bag X1314, Alice 5700, South Africa2Phytomedicine Research Group, Department of Botany, Faculty of Science and Agriculture, University of Fort Hare, P/Bag X1314, Alice 5700, South Africa3Department of Microbiology, University of Venda, Thohoyandou 0950, South Africa4Department of Biochemistry and Microbiology, Faculty of Science, University of Buea, Box 63, Buea, Cameroon
Corresponding author.
Correspondence and reprint requests should be addressed to: Prof. Roland N. Ndip Department of Biochemistry and Microbiology Faculty of Science and Agriculture University of Fort Hare PMB X 1314, Alice 5700 South Africa Fax: +27 866224759 E-mail: [email protected] OR ; Email: [email protected] is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Other Sections▼
Abstract
Infection with Helicobacter pylori is strongly associated with a number of gastroduodenal
pathologies. Antimicrobial resistance to commonly-used drugs has generated a
considerable interest in the search for novel therapeutic compounds from medicinal plants.
As an ongoing effort of this search, the susceptibility of 32 clinical strains of H. pylori and a
reference strain—NCTC 11638—was evaluated against five solvent extracts of Combretum
molle, a plant widely used for the treatment of gastric ulcers and other stomach-related
morbidities in South Africa. The extracts were screened for activity by the agar-well diffusion
method, and the most active one of them was tested against the same strains by micro-
broth dilution and time kill assays. Metronidazole and amoxicillin were included in these
experiments as positive control antibiotics. The solvent extracts all demonstrated anti-
H. pylori activity with zone diameters of inhibition between 0 and 38 mm. The most potent
anti-H. pylori activity was demonstrated by the acetone extract, to which 87.5% of the
clinical strains were susceptible. The minimum inhibitory concentration (MIC90) values for
this extract ranged from 1.25 to 5.0 mg/mL while those for amoxicillin and metronidazole
ranged from 0.001 to 0.94 mg/mL and from 0.004 to 5.0 mg/mL respectively. The acetone
extract was highly bactericidal at a concentration of 2.5 and 5.0 mg/mL, with complete
elimination of the test organisms in 24 hours. Its inhibitory activity was better than that of
metronidazole (p<0.05) as opposed to amoxicillin (p<0.05). The results demonstrate
that C. molle may contain therapeutically-useful compounds against H. pylori, which are
mostly concentrated in the acetone extract.
Key words: Acetone, Antibiotic resistance, Combretum molle, Crude extracts, Helicobacter pylori,
Microbial sensitivity tests, Minimum inhibitory concentration, South Africa
Other Sections▼
INTRODUCTION
Helicobacter pylori is a gram-negative microaerophilic spiral-shaped bacillus that affects the
gastric mucosa and can be found attached to epithelial cells of the human stomach (1).
Infection with this organism is strongly associated with chronic gastritis, peptic ulcer,
duodenal ulcer, gastric adenocarcinoma, and mucosa-associated lymphoid tissue (MALT)
lymphoma (2). The stomach of half of the world's population is colonized by this organism
(3). Treatment of H. pylori infection is relatively successful, with up to 90% of patients
exhibiting eradication of the organism with current therapeutic regimens (4). These
regimens typically involve the use of a proton pump inhibitor (PPI) or bismuth compounds in
combination with two antibiotics—most commonly amoxicillin and clarithromycin, or
metronidazole (5). However, H. pylori infection continues to be difficult to eradicate with
failure rates of up to 40% (6). A major factor to this failure is the development of antibiotic-
resistant strains (5). It is, therefore, not uncommon to find other stronger antibiotics,
particularly of the fluoroquinolone group, being part of the treatment regimen (7)
butH. pylori is also developing resistance to these drugs (8). Considering that eradication
therapies can be ineffective and undesirable side-effects may occur (9), the search for
alternative therapeutic sources for the development of new anti-H.pylori compounds is
imperative.
Other factors, including poor compliance by patients, cost of combination therapy, the
location of the organism in the stomach, and the non-availability of drugs in some rural
settings in Africa, are contraindications for some patients (3,10). Equally important is the
increasing prevalence of virulent strains, particularly those expressing the cytotoxin-
associated gene A antigen (CagA) associated with severe pathological conditions (11) that
may be difficult to manage and post-therapeutic antibiotic resistance which has been known
to decrease the cure rate by more than 50% (12). These factors have generated a
considerable interest in the search for alternative treatment regimens against this notorious
pathogen. Alternative therapeutic agents with highly-selective antibacterial activity against
the organism, without the risk of resistance or other untoward effects, are necessary (5).
Medicinal plants are among the attractive sources of new drugs and have been used for
treating gastrointestinal diseases and other ailments, particularly in the developing world
where infectious diseases are endemic and modern health facilities are not always
adequate or accessible (13). Antimicrobial compounds from plants may inhibit bacterial
growth by mechanisms different from presently-used treatment regimens and could,
therefore, be of clinical value in the treatment of resistant bacteria, including H. pylori. In
fact, our previous studies have documented that some medicinal plant extracts have
antibacterial activity against H. pylori (14).
The genus Combretum is mainly tropical and consists of numerous species,
including Combretum
molle, C. woodii, C. erythophyllum, C. Apiculatum, and C.mossambicense (15,16). They
consist of trees, climbers, and shrubs (16). Almost every part of these plants—roots, leaves,
seeds, and stem barks—is used in African traditional medicine for the treatment of parasitic,
bacterial and fungal infections (15,16). The stem bark of C. molle, a small graceful
deciduous tree (3-13 m high) is popularly used in South Africa for the treatment of stomach
pains, dysentery, gastric ulcers, abdominal disorders, and other illnesses (15). Studies on
its antibacterial properties have produced promising results (15). It is found in the traditional
medicine market where it is commercialized for medicinal purposes. Despite its traditional
uses in the treatment of gastric ulcers and other stomach-related morbidities, the activity of
this plant has not been investigated against H. pylori, a major cause of gastric ulcer. This is
surprising particularly as the prevalence of this organism is reported to vary between 50%
and 80% in South Africa (17,18), and an alarming resistance of 95.5% has been reported in
South Africa for metronidazole, one of the antibiotics used in the treatment regimen
of H. pylori infections (4). This study was, therefore, carried out to evaluate the antimicrobial
activity of C. molle on drug-resistant isolates of H. pylori. The aim was to identify the
potential sources of cheap starting materials for the synthesis of new drugs that could be
cheap and readily available to help circumvent the problem of increasing antimicrobial
resistance.
Other Sections▼
MATERIALS AND METHODS
Bacterial strains
We used 32 resistant strains of H. pylori isolated from gastric biopsies of patients with
recurrent peptic ulcer infection, despite treatment with metronidazole and amoxicillin,
undergoing endoscopy at the Livingstone Hospital, Port Elizabeth. A standard control strain
—NCTC 11638—was also included. Isolation and identification was done following our
previously-reported scheme (4). Briefly, biopsies were homogenized under aseptic
conditions in 0.2 g/L of cysteine and 20% of glycerol in Brain heart infusion (BHI) broth
(Oxoid, England). A loopful of the homogenate was plated on freshly-prepared Columbia
agar base (Oxoid, England) supplemented with 6% horse blood and Skirrow's supplement
(Oxoid, England) containing trimethoprim (2.5 mg), vancomycin (5 mg), cefsulodin (2.5 mg),
and amphotericin (2.5 mg). Inoculated plates were incubated at 37 °C for five days under
microaerophilic conditions (5-6% O2, 10% CO2, and 80-85% N2) (Anaerocult Basingstoke,
Hampshire, England). The isolates were identified based on colony morphology, positive
oxidase, urease, catalase tests, and amplification of the glmM gene. Confirmed isolates
were suspended in eppendorf tubes containing 1 mL of BHI broth and 20% glycerol and
stored at −80 °C until future use. Gastric biopsies were only collected from patients who had
given consent and had not been on antibiotics, PPI, or bismuth salts for at least a week.
Preparation of plant material
The stem bark of C. molle R. Br. Ex G. Don (Combretaceae) was harvested in the vicinity of
the University of Venda, Limpopo province, and transported in plastic bags to the School of
Biological Sciences, University of Fort Hare, where they were identified and vouchers were
deposited in the school's herbarium (CNUFH05). The plant material was washed, air-dried
for two weeks, and ground to fine powder using a blender (ATO MSE mix, England).
Preparation of plant extracts
Exactly 300 g of dried plant material was macerated separately in 600 mL of concentrated
ethyl acetate, acetone, ethanol, and methanol in large glass bottles (SIMAX, Czech
Republic). Aqueous extracts were also prepared by soaking the same amount of plant
material in tap water. The bottles were labelled and put in an orbital shaker for 48 hours.
The plant extracts were centrifuged at 1,006.2 g for five minutes at 4 °C and filtered using a
fritted filter funnel of pore size 60 Å. The procedure was repeated twice, and the three
extracts were combined and evaporated to dryness under vacuum in a rotary evaporator
(BUCHI rota vapour, Flavil/Schweiz, Switzerland). The filtrate obtained from the aqueous
extract was lyophilized (19). The dried crude extracts were collected in clean glass Petri-
dishes and left open in a biosafety class II cabinet (Durban, South Africa) for complete
evaporation of residual solvents. A 2-g sample of each extract was used for the preliminary
bioassay, and where possible, another 2 g or more was put in universal bottles and kept in
the extract bank. Stock solutions were prepared by dissolving the extracts in 10% dimethyl
sulphoxide (DMSO) or 80% acetone (neither DMSO nor acetone was inhibitory to
the H. pylori strains at the tested concentrations).
Screening of crude extracts for anti-H. pylori activity
This was done by the agar-well diffusion method as previously reported (20).
Briefly,H. pylori inocula prepared at McFarland's turbidity standard 2 were plated onto BHI
agar supplemented with 5% horse blood and Skirrow's supplement (Oxoid, England). The
inocula were evenly spread on the plate. The plate was allowed to dry for about 15 minutes.
Wells (6 mm in diameter) were punched into the agar using a sterile stainless steel borer.
The wells were filled with 65 μL of the extract at 100 mg/mL. Sixty-five μL of 0.05 μg/mL of
clarithromycin and 10% DMSO were included in all the experiments as positive and
negative controls respectively. The plates were incubated under microaerophilic conditions
(Anaerocult, Oxoid, UK) at 37 °C for 72 hours after which the diameters of zones of
inhibition were measured in mm. The experiment was repeated once, and the mean zones
were recorded. A zone diameter of ≥14 mm was used as breakpoint susceptibility for
clarithromycin and the extracts; this was also used for calculating their percentage
susceptibilities (1). A plate inoculated with a reference strain (NCTC 11638) of H. pylori was
included in all the experimental runs.
Determination of minimum inhibitory concentration (MIC90)
The acetone extract which was the only extract to which more than 50% of the strains were
susceptible was chosen for further determination of MIC by the micro-broth dilution method
as earlier reported (21). The test was performed in 96-well plates. The test extract was
prepared at a concentration of 5.0 mg/mL and filtered through a 2.0-μm filter (Acrodisc Pall,
MI, USA). Two-fold dilutions of the extract were made in the test wells in BHI broth
supplemented with 5% horse serum and Skirrow's supplement (Oxoid, England). The final
extract concentration ranged from 0.001 to 5.0 mg/mL. Twenty μL of an 18-hour old broth
culture of H. pylori (McFarland's turbidity standard 2) suspension was added to 100 μL of
extract-containing culture medium. Control wells were prepared with culture medium plus
bacterial suspension and broth only respectively. Metronidazole and amoxicillin were run,
alongside the extract at concentration ranges of 0.005-5.0 mg/mL and 0.001-1.25 mg/mL
respectively. An automatic ELISA micro-plate reader (Tokyo, Japan) adjusted to 620 nm
was used for measuring the absorbance of the plates. The plates were incubated at 37 °C
for 72 hours under microaerophilic conditions (Anaerocult Basingstoke, Hampshire,
England), and the absorbance was read again at 620 nm. The initial and the post-incubation
absorbencies were compared to detect an increase or a decrease in bacterial growth. The
lowest concentration of the test extract resulting in inhibition of 90% of bacterial growth was
recorded as the MIC. The strains were considered susceptible to the control antibiotics if
their MIC90 values were <0.002 mg/mL for amoxicillin and <0.008 mg/mL for metronidazole
(1).
Determination of rate of killing
The rate and extent of killing of H. pylori by the acetone extract of C. molle was determined
as described by Akinpelu et al. (22) with slight modifications. The turbidity of an 18-hour old
broth culture of H. pylori was standardized to 108 CFU/mL. One mL of this suspension was
added to 9 mL of BHI broth supplemented with 5% horse serum and Skirrow's reagents
containing the extract at 0.625 mg/mL (MIC/2), 1.25 mg/mL (MIC), 2.50 mg/mL (2 MIC), and
5.0 mg/mL (4 MIC) in McCartney bottles (Oxoid, England). A negative control bottle was
prepared with bacterial suspension and broth only. A 0.1-mL sample was plated from these
bottles before incubation at 37 °C under microaerophilic conditions. Exactly 0.5 mL of each
suspension was withdrawn at a six-hour interval for 72 hours and transferred to 4.5 mL of
BHI broth recovery medium containing 3% ‘Tween 80’ to neutralize the effects of the
antimicrobial extract carry-overs from the test organisms. The suspension was 10-fold
serially diluted in sterile saline (0.9% w/v sodium chloride) and plated in triplicates. The
plates were incubated at 37 °C for 72 hours under microaerophilic conditions, and the viable
counts were determined.
Statistical analysis
Results were expressed as mean±standard deviation using the SPSS software (version
17.0) (Chicago, Illinois, 2009) and Excel. One-way analysis of variance (ANOVA), followed
by Turkey's post-hoc test, was used for comparing the mean difference in inhibitory
activities of extracts and antibiotics. The differences were considered significant at p<0.05.
Ethical approval
The Eastern Cape Department of Health and the Govan Mbeki Research and Development
Centre, University of Fort Hare, approved the study.
Other Sections▼
RESULTS
Extract yield
The total amount of crude extract obtained with the different solvents showed that methanol
was quantitatively the best solvent for extraction, with a crude extract yield of 5.1 g (1.7%),
followed by acetone 4.6 g (1.5%), ethanol 3.2 g (1.1%), water 3.1 g (1.0%), and ethyl
acetate 1.3 (0.4%). Ethyl acetate, acetone and methanol extracts were dark brown in colour
while ethanol and aqueous extracts appeared as brown to light brown crystals.
Antimicrobial susceptibility testing and determination of minimum inhibitory concentration
All the crude extracts tested in this study demonstrated antimicrobial activity with zone
diameters of inhibition ranging from 0 to 38 mm (Table 1). The highest zone diameter of 38
mm was recorded for the acetone extract, to which 87.5% of the clinical strains were
susceptible (Fig. 1). Zone diameters of inhibition for the acetone extract were significantly
different from the other extracts (p<0.05) as opposed to the control antibiotic (p>0.05)
(Table 1). Eleven (34.4%) and six (18.8%) of the 32 strains tested against the acetone and
ethanol extracts respectively recorded susceptible zones of inhibition as opposed to the
positive control which was resistant but the differences were not significant (p>0.05).
Table 1.Screening of crude extracts of C. molle against H. pylori isolates
Fig. 1.Anti-H. pylori activity of crude extracts of C. molle by agar well diffusion method
The MIC values for the acetone extract ranged from 1.25 to 5.0 mg/mL while those for
amoxicillin and metronidazole ranged from 0.001 to 0.94 mg/mL and 0.004 to 5.0 mg/mL
respectively (Table 2).
Table 2.Minimum inhibitory concentration (90%) of C. molleand control antibiotics (mg/mL)
Bactericidal activity
The acetone extract of C. molle exhibited considerable bactericidal activity against the
isolates at all concentrations tested over a 72-hour period. The test organisms were
completely eliminated at a concentration of 2.5 and 5.0 mg/mL within 24 hours (Fig. 2). No
cells were killed in the first six hours of the experiment at all the extract concentrations
tested.
Fig. 2.Effect of crude acetone extracts of C. molle on the growth of H. pylori
Other Sections▼
DISCUSSION
Post-therapeutic antibiotic-resistant H. pylori reduces the cure rate of infection by up to 66%
(12). With very few exceptions, the most commonly-recommended treatment regimen (PPI,
amoxicillin, and clarithromycin or metronidazole) now provides unacceptably low treatment
successes (23), with approximately one in five patients requiring second and third-line
therapies due to eradication failure (12). It should, therefore, not be surprising that all the
clinical strains tested in this study were resistant to metronidazole and amoxicillin
considering that they were isolated from patients who had been on treatment regimens
involving these drugs (4). We were, therefore, probably dealing with a small group of
patients with a high level of post-therapeutic resistance confirmed by the high MIC values
observed.
Other studies have reported high metronidazole and amoxicillin resistance in the developing
world (1,4,5,24). Metronidazole resistance is an existing problem in this part of the world
and is probably due to drug pressure because this inexpensive drug is also used in the
treatment of gynaecological problems and protozoa infections (1,4) while amoxicillin
resistance can be attributed to the non-adherence to drug-prescription protocols.
Consequently, an increased eradication failure will be observed with treatment regimens
involving these drugs. Antimicrobial susceptibility testing to establish resistance patterns,
therefore, becomes imperative to guide empiric treatment. Other measures, such as strict
antibiotic restriction practices, education of the population, and pharmacovigilance will go a
long way to improve the management of antibiotic use in the developing world.
Our results showed that methanol was quantitatively the best solvent for extraction.
Different solvents may be employed in the extraction of antimicrobial compounds from
plants; however, the success in the isolation process is largely dependent on the type of
solvent used (25). The good extracting ability of methanol recorded in this study
corroborates findings of other studies (25-27), thus confirming this solvent as a good
extractant of phytochemicals from Combretum species and other plants. However, the
quantity of extract may not always relate proportionately to the activity as revealed by the
low anti-H. pylori activity of the methanol extract recorded herein. Nevertheless, extracts
with little or no activity in vitro may have properties similar to pro-drugs which are
administered in an inactive form. Their metabolites could be active in vivo (14).
The results of this study indicate that the ethanol and methanol extracts were only minimally
active (Fig. 1). However, in a study on rats in Brazil by Nunes et al. (28), the ethanolic
extract of the stem bark of a local Combretum species—C. leprosum—exhibited anti-
ulcerogenic and gastro-protective effects by increasing the volume and pH of gastric juice
while decreasing the acid output (28). Although Nunes et al. did not investigate the
antimicrobial activity of their extracts against H. pylori (28), the effects demonstrated by the
crude ethanolic extract of C. leprosum in the animal model could be useful in preventing the
development of severe pathological conditions in anH. pylori-infected mucosa.
The zone of inhibition diameters and percentage susceptibilities seem to decrease with
increase in polarity of the solvent from ethanol to water (Fig. 1), which may imply that the
isolates were not very sensitive to the polar compounds of this plant or at least, not many
anti-H. pylori compounds were extracted by polar solvents. However, the activity
demonstrated by these extracts indicates their potential as useful bioactive substances.
The acetone extract demonstrated remarkable activity against the test strains in the entire
study. This indicates that the active components of this plant are more soluble in acetone
and have a good antimicrobial potential. Further investigation may lead to the isolation of
potentially-useful compounds for the treatment of H. pylori infections. The activity of this
extract compared favourably with metronidazole, with no significant differences between
their mean MIC values (p>0.05). This is remarkable considering that all the clinical strains
used in this study were resistant to the antibiotics.
The extract was also strongly bactericidal at a concentration of 2.5 and 5.0 mg/mL, with
complete elimination of the organisms in 24 hours (Fig. 2). However, active components in
the crude extract may be acting in synergism to produce greater antimicrobial effects (29).
In any case, the acetone extract of C. molle may be considered a possible new source of
compounds for the management of infections caused by resistant strains of H. pylori. This is
particularly important in the study area given the current trend and ever-evolving nature of
resistant H. pylori (4).
Acetone is used for extracting mostly flavonoids and steroids (15,30,31). Flavonoids are
known to be synthesized by plants in response to microbial infection (32,33), which may
account for their antimicrobial activity against a wide range of organisms.
Several studies have reported on the good antimicrobial activity of the ethyl acetate fraction
of Combretum species (34,35) but H. pylori was not among the organisms tested. Our
findings provide preliminary evidence that the ethyl acetate extract of C.molle has very little
activity against H. pylori. The aqueous extracts of C. molle also showed very little activity
(6.3%) against H. pylori (Fig. 1). Other studies have also reported very low antimicrobial
activity of the aqueous extract of other members of the Combretaceae and other plants
(15,35). Despite its availability and relatively low toxicity, water may still not be a suitable
solvent for the extraction of anti-H. pyloricompounds from C. molle.
Conclusions
The results of the study provide preliminary scientific validation of the traditional medicinal
use of this plant in the treatment of infections symptomatic of H. pylori. This plant may
contain compounds, mostly in the acetone crude extract that could be used as lead
molecules for the synthesis of novel drugs against recurrent and
resistant H. pylori infections. Isolation and characterization of the biologically-active
constituents of the acetone extract of C. molle and a detailed assessment of their in-
vivo potencies will add more value to their potential usefulness as anti-H. pyloriagents.
These aspects are already receiving attention in our group.
ACKNOWLEDGEMENTS
The authors are grateful to the National Research Foundation, South Africa (Grant No.
CSUR 2008052900010) and the Govan Mbeki Research and Development Centre,
University of Fort Hare, South Africa, for funding the study. They thank Dr. Naidoo N, Dr.
Tanih NF, Mr. Okeleye BI, and Mr. Tshikhawe P for technical assistance.
Other Sections▼
REFERENCES
1. Ndip RN, Malange TAE, Ojongokpoko JEA, Luma HN, Malongue A, Akoachere JFK, et al.Helicobacter
pylori isolates recovered from gastric biopsies of patients with gastro-duodenal pathologies in Cameroon: current
status of antibiogram. Trop Med Inter Health. 2008;13:848–54.
2. Adeniyi CB, Lawal TO, Mahady GB. In vitro susceptibility of Helicobacter pylori to extracts ofEucalyptus
camaldulensisEucalyptus torelliana. Pharmaceut Biol. 2009;47:99–102.
3. Romano M, Cuomo A. Eradication of Helicobacter pylori: a clinical update. Med Gen Med.2004;6:19.
4. Tanih NF, Okeleye BI, Naidoo N, Clarke AM, Mkwetshana N, Green E, et al. Marked susceptibility of South
African Helicobacter pylori strains to ciprofloxacin and amoxicillin: clinical implication. S Afr Med J. 2010;100:49–
52. [PubMed]
5. Njume C, Afolayan AJ, Ndip RN. An overview of antimicrobial resistance and the future of medicinal plants in the
treatment of Helicobacter pylori infections. Afr J Pharm Pharmacol. 2009;3:685–99.
6. Lai CH, Kuo CH, Chen PY, Poon SK, Chang CS, Wang WC. Association of antibiotic resistance and higher
internalization activity in resistant Helicobacter pylori isolates. J Antimicrob Chemother.2006;57:466–71. [PubMed]
7. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the
management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut.2007;56:772–81. [PMC free
article] [PubMed]
8. Eisig JN, Silva FM, Barbuti RC, Rodriguez TN, Malfertheiner P, Moraes Filho JP, et al. Efficacy of a 7-day course
of furazolidone, levofloxacin, and lansoprazole after failed Helicobacter pylorieradication. BMC
Gastroenterol. 2009;9:38. [PMC free article] [PubMed]
9. Aboderin OA, Abdu AR, Odetoyin B, Okeke IN, Lawal OO, Ndububa DA, et al. Antibiotic resistance ofHelicobacter
pylori from patients in Ile-Ife, South-West, Nigeria. Afr Health Sci. 2007;7:143–7.[PMC free article] [PubMed]
10. Me´Graud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol
Rev. 2007;20:280–322. [PMC free article] [PubMed]
11. Tanih NF, McMillan M, Naidoo N, Ndip LM, Weaver LT, Ndip RN. Prevalence of Helicobacter pyloriVacA, CagA
and iceA genotypes in South African patients with upper gastrointestinal diseases. Acta tropica. 2010;116:68–
73. [PubMed]
12. Bohr UR, Malfertheiner P. Eradication of H. pylori infection: the challenge is on if standard therapy
fails. Therapeut Advan Gastroenterol. 2009;2:59–66.
13. Samie A, Obi CL, Bessong PO, Namrita L. Activity profiles of fourteen selected medicinal plants from rural Venda
communities in South Africa against fifteen clinical bacterial species. Afr J Biotechnol. 2005;4:1443–51.
14. Ndip RN, Malange Tarkang AE, Mbullah SM, Luma HN, Malongue A, Ndip LM, et al. In vitro anti-Helicobacter
pylori activity of extracts of selected medicinal plants from North West Cameroon. J Ethnophamacol. 2007;114:452–
7.
15. Eloff JN, Katerere DR, Mcgaw LJ. The biological activi-ty and chemistry of the southern African Combretaceae. J
Ethnopharmacol. 2008;119:686–99. [PubMed]
16. Elegami AA, Osman SM, Omer ME, Ishag KM. In-vitro-antibacterial activity of some
SudaneseCombretum species. Inter J Trop Med. 2007;2:45–51.
17. Samie A, Obi CL, Barrett LJ, Powell SM, Guerrant RL. Prevalence of Campylobacter species,Helicobacter
pyloriArcobacter species in stool samples from the Venda region, Limpopo, South Africa: studies using molecular
diagnostic methods. J Infect Dis. 2007;54:558–66.
18. Dube C, Nkosi TC, Clarke AM, Mkwetshana N, Green E, Ndip RN. Helicobacter pyloriantigenemia in an
asymptomatic population of the Eastern Cape province, South Africa: public health implications. Rev Environ
Health. 2009;24:249–55. [PubMed]
19. Castillo-Juárez I, González V, Aime-Aguilar H, Martínez G, Linares E, Bye R, et al. Anti-Helicobacter
pylori activity of plants used in Mexican traditional medicine for gastrointestinal disorders. J
Ethnopharmacol. 2009;122:402–5. [PubMed]
20. Boyanova L, Gergova G, Nikolov R, Derejian S, Lazarova E, Katsarov N, et al. Activity of Bulgarian propolis
against 94 Helicobacter pylori strains in vitro by agar-well diffusion, agar dilution and disc diffusion methods. J Med
Microbiol. 2005;54:481–3. [PubMed]
21. Bonacorsi C, Raddi MS, Carlos IZ, Sannomiya M, Vilegas W. Anti-Helicobacter pylori activity and
immunostimulatory effect of extracts from Byrsonima crassa Nied. BMC Complement Alternat Med.2009;9:2.
22. Akinpelu DA, Aiyegoro AO, Okoh AI. Studies on the biocidal and cell membrane disruption potentials of stem bark
extracts of Afzelia africana (Smith) Biol Res. 2009;42:339–49. [PubMed]
23. Graham D, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic
resistance. Gut. 2010;59:1143–53. [PubMed]
24. Smith SI, Oyedeji KS, Arigbabu AO, Atimomo C, Coker AO. High amoxicillin resistance inHelicobacter
pylori isolated from gastritis and peptic ulcer patients in Western Nigeria. J Gastroenterol. 2001;36:67–8. [PubMed]
25. Masoko P, Picard J, Eloff JN. The antifungal activity of twenty-four Southern African Combretumspecies
(Combretaceae) S Afr J Bot. 2007;73:173–83.
26. Fyhrquist P, Mwasumbi L, Hæggström CA, Vuorela H, Hiltunen R, Vuorela P. Ethnobotanical and antimicrobial
investigation on some species of TerminaliaCombretum (Combretaceae) growing in Tanzania. J
Ethnopharmacol. 2002;79:169–77. [PubMed]
27. Ezekiel CN, Anokwuru CP, Nsofor E, Odusanya OA, Adebanjo O. Antimicrobial activity of the methanolic and
crude alkaloid extracts of Acalypha wilkesiana cv. macafeeana copper leaf. Res J Microbiol. 2009;4:269–77.
28. Nunes PH, Cavalcanti PM, Galvão SM, Martins MC. Antiulcerogenic activity of. Combretum leprosum.
Pharmazie. 2009;64:58–62.
29. Eloff JN. Which extractant should be used for the screening and isolation of antimicrobial components from
plants? J Ethnopharmacol. 1998;60:1–8. [PubMed]
30. Cowan MM. Plant products as antimicrobial agents. Clin Microbiol Rev. 1999;12:564–82.[PMC free
article] [PubMed]
31. Afolayan AJ, Lewu FB. Antimicrobial activity of. Alepidea amatymbica. Pharmaceut Biol.2009;47:436–9.
32. Hernández NE, Tereschuk ML, Abdala LR. Antimicrobial activity of flavonoids in medicinal plants from Tafí del
Valle (Tucumán, Argentina) J Ethnopharmacol. 2000;73:317–22. [PubMed]
33. Schinor EC, Salvador MJ, Ito IY, Dias DA. Evaluation of the antimicrobial activity of crude extracts and isolated
constituents from. Chresta scapigera. Brazil J Microbiol. 2007;38:145–9.
34. Onocha PA, Audu EO, Ekundayo O, Dosumu OO. Phytochemical and antimicrobial properties of extracts
of. Combretum racemosum. Acta Hort. 2005;675:97–101.
35. Eloff JN, Famakin JO, Katerere DRP. Combretum woodii (Combretaceae) leaf extracts have high activity against
gram-negative and gram-positive bacteria. Afr J Biotechnol. 2005;4:1161–6.
Top Related